Multiple Sclerosis Management for PTs: What to Expect and What to Do About It
Section: Academy of Neurologic PT
Session Code: NE-2A-6703
Date: Friday, January 25, 2019
Time: 8:00 AM - 10:00 AM
Location: Walter E. Washington Convention Center
Room: Salon ABC

Speaker(s):   Evan Cohen, PT, PhD, MA, Board-Certified Clinical Specialist in Neurologic Physical Therapy
  Herb Karpatkin, PT, DSc, MSCS, Board-Certified Clinical Specialist in Neurologic Physical Therapy

Session Type: Educational Sessions
Session Level: Basic

Description:
The prevalence of multiple sclerosis (MS) is rising in the United States, leading to an increase in the number of physical therapy referrals. Although MS often has a primary impact on mobility, there is a paucity of evidence regarding rehabilitation management. Much of this is due to the multifactorial nature of the disease. Because MS is a progressive disease, expectations must be tempered with the understanding that the disease may worsen in severity and evolve in clinical presentation over time. As such, PTs must be vigilant and prepared to change the focus of practice over the disease course. In this session, the speakers will present information related to the disease prognosis, specifically how various aspects related to diagnosis, comorbidities, and social factors can impact clinical presentation over the spectrum of time. They also will describe options for physical therapy examination and interventions that reduce the incidence of complications arising from the disease as it progresses. This session will provide attendees with evidence-based tools to address issues related to disease progression and likely problems with body structure/function, activity, and participation, as well as how these tools can be quickly integrated into contemporary clinical practice.

Learning Objectives: Upon completion of this course, you will be able to:

1. Differentiate factors that affect disease and disability prognosis in people with multiple sclerosis.

2. Select appropriate measures for physical therapy examination and evaluation based on expected patient presentation across the spectrum of disability and continuum of time, with a focus on identifying preclinical signs and symptoms.

3. Develop an intervention plan that reflects examination and evaluation findings to prevent problems with body structure/function and activity commonly experienced by people with multiple sclerosis throughout the disease spectrum.


CEU: 0.2






Search sessions by day, speaker, section, keyword, event type, or display all sessions.


Return to Main Menu Return to CSM Programming Page

Copyright © 2019 APTA